N@N

MEDTOX SCIENTIFIC, INC. (NASDAQ:MTOX), Down By 5.81% ($0.79) From $13.600 After BUYINS.NET Report Predicted Stock Would Go Down

^{Published on 2011-12-14 09:41:28 - WOPRAI}
 

December 14, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, December 12th 2011 stating that MEDTOX SCIENTIFIC, INC. (NASDAQ:MTOX) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=mtox&id=220795

At the time this story was written, MEDTOX SCIENTIFIC, INC. (NASDAQ:MTOX) is Down By $0.79 (5.81%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

MEDTOX SCIENTIFIC, INC. (NASDAQ:MTOX) - MEDTOX Scientific, Inc. and its subsidiaries provide forensic and clinical laboratory services. The company also manufactures and distributes diagnostic and related devices. Its Laboratory Services segment offers drugs-of-abuse testing services. It also provides clinical and other laboratory services, including clinical toxicology, clinical testing for occupational health clinics, clinical testing for physician offices, pediatric lead testing, and analysis of heavy and trace metal. In addition, this segment offers services in the area of logistical support, data management, and program management; and pain management products. Further, it provides clinical trial services comprising central laboratory, assay (test) development, bio-analytical, bio-equivalence, and pharmacokinetic testing services for pharmaceutical and biotech companies, clinical research organizations, research organizations, investigators with trial management, and patient recruitment/enrollment and site management organizations. The companys Product Sales segment offers point-of-collection testing (POCT) products for drugs-of-abuse. It primarily provides diagnostic drug screening products, such as PROFILE-II ER and PROFILE-III ER, and PROFILE-IV to hospital markets for drug detection in patients; MEDTOXScan, an electronic reader for use with PROFILE-V device in hospital laboratories and emergency rooms; and VERDICT-II and SURE-SCREEN diagnostic drug screening products for criminal justice and drug rehabilitation markets. This segment also offers coagulation/blood clotting market controls; and distributes diagnostic tests for the detection of alcohol with the EZ-SCREEN Breath Alcohol Test. The company serves public and private companies, drug treatment counseling centers, criminal justice facilities, occupational health clinics, third party administrators, and hospitals. MEDTOX Scientific, Inc. was founded in 1983 and is based in St. Paul, Minnesota.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net